Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
Use this KROS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KROS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KROS SEC filings page. Lician reads the product cache first so this HTML stays unique to Keros Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KROS income, balance, and cash tables.